APhA Urges FDA to Put Patient Safety First in Review of Peptide Substances
July 18, 2026
July 18, 2026
WASHINGTON, July 18 -- The American Pharmacists Association issued the following news release:
* * *
APhA urges FDA to put patient safety first in review of peptide substances
As the market for unregulated peptide products continues to grow, the American Pharmacists Association (APhA) is urging FDA and the Pharmacy Compounding Advisory Committee (PCAC) to prioritize patient safety, scientific evidence, and regulatory oversight as they evaluate several pepti . . .
* * *
APhA urges FDA to put patient safety first in review of peptide substances
As the market for unregulated peptide products continues to grow, the American Pharmacists Association (APhA) is urging FDA and the Pharmacy Compounding Advisory Committee (PCAC) to prioritize patient safety, scientific evidence, and regulatory oversight as they evaluate several pepti . . .